2024
DOI: 10.1136/rmdopen-2023-003820
|View full text |Cite
|
Sign up to set email alerts
|

Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases

Mauro Fatica,
Benedetta Monosi,
Paola Conigliaro
et al.

Abstract: ObjectiveEvaluate spondyloarthritis (SpA) incidence in inflammatory bowel diseases (IBD) between patients treated with biological disease-modifying antirheumatic drugs (bDMARDs) and conventional DMARDs (cDMARDs) and define risk factors associated with SpA development.MethodsRetrospective cohort study was conducted on patients with Crohn’s disease (CD) or ulcerative colitis (UC) and divided into two cohorts: cDMARDs or bDMARDs/targeted synthetic (ts) DMARDs treated patients. Rheumatological assessment was perfo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
references
References 42 publications
0
0
0
Order By: Relevance